By [Your Name] In a significant move that has sent ripples through the pharmaceutical industry, West Pharmaceutical Services, Inc. (WST) has announced an upward revision of its fiscal year 2024 (FY24) adjusted earnings per share (EPS) guidance. The company now expects to achieve an adjusteddiluted EPS in the range of $6.55 to $6.75, up from its previous forecast of $6.35 to $6.65..
Executive Summary West Pharmaceutical Services, Inc..
Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!